Cytoreductive procedures-strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks.
Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for the therapy of peritoneal carcinomatosis are associated with substantial morbidity and acceptable mortality. Patient selection, learning curve, patient warming, and reduced blood loss are the main factors to decrease morbidity. Morbidity is mostly associated with bowl fistulas and anastomotic leakages. Depending on the site of leaks they may be managed conservatively or by reoperation. For standardization of study reports on morbidity and mortality the CTCAE classification is recommended.
Jaehne
Joachim
J
Department of General and Visceral Surgery, Diakoniekrankenhaus Henriettenstiftung gGmbH, Hannover, Germany. joachim.jaehne@henriettenstiftung.de
D000714:Anastomosis, Surgical / Q000009:adverse effects*; D006801:Humans; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000601:surgery*; D011183:Postoperative Complications / Q000175:diagnosis / Q000517:prevention & control*